BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsuji E, Hiki N, Nomura S, Fukushima R, Kojima J, Ogawa T, Mafune K, Mimura Y, Kaminishi M. Simultaneous onset of acute inflammatory response, sepsis-like symptoms and intestinal mucosal injury after cancer chemotherapy. Int J Cancer. 2003;107:303-308. [PMID: 12949812 DOI: 10.1002/ijc.11196] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 张敏, 陈锦秀, 谭景予, 刘贤亮. 化疗致胃肠道黏膜炎动物模型构建方法的研究进展. 世界华人消化杂志 2012; 20(8): 649-655 [DOI: 10.11569/wcjd.v20.i8.649] [Reference Citation Analysis]
2 Wang W, Quan W, Yang F, Wei Y, Chen J, Yu H, Xie J, Zhang Y, Li Z. RBM4 modulates the proliferation and expression of inflammatory factors via the alternative splicing of regulatory factors in HeLa cells. Mol Genet Genomics 2020;295:95-106. [DOI: 10.1007/s00438-019-01606-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wei L, Wang J, Yan L, Shui S, Wang L, Zheng W, Liu S, Liu C, Zheng L. Sulforaphane attenuates 5-fluorouracil induced intestinal injury in mice. Journal of Functional Foods 2020;69:103965. [DOI: 10.1016/j.jff.2020.103965] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
4 Moriya T, Fukatsu K, Noguchi M, Okamoto K, Murakoshi S, Saitoh D, Miyazaki M, Hase K, Yamamoto J. Intravenous Administration of High-Dose Paclitaxel Reduces Gut-Associated Lymphoid Tissue Cell Number and Respiratory Immunoglobulin A Concentrations in Mice. Surgical Infections 2014;15:50-7. [DOI: 10.1089/sur.2012.101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Blijlevens NM. Cytotoxic treatment-induced gastrointestinal symptoms. Current Opinion in Supportive & Palliative Care 2007;1:16-22. [DOI: 10.1097/spc.0b013e3281108025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
6 Sebe M, Tsutsumi R, Yamaguchi S, Horikawa YT, Harada N, Oyama T, Kakuta N, Tanaka K, Tsutsumi YM, Nakaya Y, Sakaue H. The synergystic effects of omega-3 fatty acids against 5-fluorouracil-induced mucosal impairment in mice. BMC Nutr 2016;2. [DOI: 10.1186/s40795-016-0057-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Franchelli S, Vassallo F, Porzio C, Mannucci M, Priano V, Schenone E, Leone MS, Canavese G, Santi P, De Maria A. Breast Implant Infections after Surgical Reconstruction in Patients with Breast Cancer: Assessment of Risk Factors and Pathogens over Extended Post-Operative Observation. Surgical Infections 2012;13:154-8. [DOI: 10.1089/sur.2011.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
8 Yu H, Hou Z, Yang X, Mou Y, Guo C. Design, Synthesis, and Mechanism of Dihydroartemisinin⁻Coumarin Hybrids as Potential Anti-Neuroinflammatory Agents. Molecules 2019;24:E1672. [PMID: 31035404 DOI: 10.3390/molecules24091672] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Fritz JV, Heintz-Buschart A, Ghosal A, Wampach L, Etheridge A, Galas D, Wilmes P. Sources and Functions of Extracellular Small RNAs in Human Circulation. Annu Rev Nutr 2016;36:301-36. [PMID: 27215587 DOI: 10.1146/annurev-nutr-071715-050711] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 13.6] [Reference Citation Analysis]
10 Blijlevens NM, Logan RM, Netea MG. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Mucositis: from febrile neutropenia to febrile mucositis. J Antimicrob Chemother 2009;63 Suppl 1:i36-40. [PMID: 19372181 DOI: 10.1093/jac/dkp081] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
11 van der Velden WJ, Herbers AH, Feuth T, Schaap NP, Donnelly JP, Blijlevens NM. Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantation. PLoS One 2010;5:e15156. [PMID: 21188146 DOI: 10.1371/journal.pone.0015156] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 6.1] [Reference Citation Analysis]
12 Cai B, Wan P, Sun H, Chen D, Chen H, Chen X, Pan J. Protective Effects of Enteral Nutrition Supplemented with Crassostrea hongkongensis Polysaccharides Against 5-Fluorouracil-Induced Intestinal Mucosal Damage in Rats. J Med Food 2018;21:348-55. [PMID: 29432052 DOI: 10.1089/jmf.2017.4025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
13 Zirakzadeh A, Gastineau DA, Mandrekar JN, Burke JP, Johnston PB, Patel R. Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2008;41:385-92. [PMID: 18084341 DOI: 10.1038/sj.bmt.1705912] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
14 de Mooij CEM, Netea MG, van der Velden WJFM, Blijlevens NMA. Targeting the interleukin-1 pathway in patients with hematological disorders. Blood 2017;129:3155-64. [PMID: 28483765 DOI: 10.1182/blood-2016-12-754994] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
15 van der Velden WJFM, Blijlevens NMA, Feuth T, Donnelly JP. Febrile mucositis in haematopoietic SCT recipients. Bone Marrow Transplant 2009;43:55-60. [DOI: 10.1038/bmt.2008.270] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
16 van der Velden WJ, Herbers AH, Netea MG, Blijlevens NM. Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis. Br J Haematol. 2014;167:441-452. [PMID: 25196917 DOI: 10.1111/bjh.13113] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 9.1] [Reference Citation Analysis]
17 Murakami M, Sato N, Tashiro K, Nakamura T, Masunaga H. Effects of caloric intake on intestinal mucosal morphology and immune cells in rats treated with 5-Fluorouracil. J Clin Biochem Nutr. 2009;45:74-81. [PMID: 19590710 DOI: 10.3164/jcbn.08-264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
18 McCann S, Schwenkglenks M, Bacon P, Einsele H, D'Addio A, Maertens J, Niederwieser D, Rabitsch W, Roosaar A, Ruutu T, Schouten H, Stone R, Vorkurka S, Quinn B, Blijlevens N; EBMT Mucositis Advisory Group. The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT. Bone Marrow Transplant 2009;43:141-7. [PMID: 18776926 DOI: 10.1038/bmt.2008.299] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
19 Abalo R, Uranga JA, Pérez-García I, de Andrés R, Girón R, Vera G, López-Pérez AE, Martín-Fontelles MI. May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat. Neurogastroenterol Motil 2017;29. [PMID: 27686064 DOI: 10.1111/nmo.12952] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
20 Kajiwara T, Miura K, Ohnuma S, Shimada M, Komura T, Toshima M, Kohyama A, Kudoh K, Haneda S, Musha H, Naitoh T, Shirasaka T, Unno M. Gastrointestinal toxicities of 5-fluorouracil increase the proportion of regulatory T cells in intestinal tract: advantages of alternate-day S-1 administration. Int J Clin Oncol 2015;20:913-21. [PMID: 25652909 DOI: 10.1007/s10147-015-0791-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
21 Smith LB, Leo MC, Anderson C, Wright TJ, Weymann KB, Wood LJ. The role of IL-1β and TNF-α signaling in the genesis of cancer treatment related symptoms (CTRS): a study using cytokine receptor-deficient mice. Brain Behav Immun 2014;38:66-76. [PMID: 24412646 DOI: 10.1016/j.bbi.2013.12.022] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
22 Ueno K, Ajiki T, Tsugawa D, Akita M, Hashimoto Y, Awazu M, Mukubo H, Komatsu S, Kuramitsu K, Terai S, Tanaka M, Toyama H, Kido M, Fukumoto T. Effectiveness of omega-3 fatty acid administration on completion rate of adjuvant chemotherapy for biliary tract cancer: study protocol for a single-centre, open-label, single-arm, historically controlled study. BMJ Open 2019;9:e029915. [PMID: 31401605 DOI: 10.1136/bmjopen-2019-029915] [Reference Citation Analysis]
23 Wardill HR, de Mooij CEM, da Silva Ferreira AR, van de Peppel IP, Havinga R, Harmsen HJM, Tissing WJE, Blijlevens NMA. Translational model of melphalan-induced gut toxicity reveals drug-host-microbe interactions that drive tissue injury and fever. Cancer Chemother Pharmacol 2021;88:173-88. [PMID: 33877390 DOI: 10.1007/s00280-021-04273-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Vandijck DM, Benoit DD, Depuydt PO, Offner FC, Blot SI, Van Tilborgh AK, Nollet J, Steel E, Noens LA, Decruyenaere JM. Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies. Intensive Care Med 2008;34:847-55. [PMID: 18214437 DOI: 10.1007/s00134-008-1002-2] [Cited by in Crossref: 79] [Cited by in F6Publishing: 68] [Article Influence: 6.1] [Reference Citation Analysis]
25 Ota A, Morita S, Matsuoka A, Shimokata T, Maeda O, Mitsuma A, Yagi T, Asahara T, Ando Y. Detection of bacteria in blood circulation in patients receiving cancer chemotherapy. Int J Clin Oncol 2020;25:210-5. [PMID: 31407169 DOI: 10.1007/s10147-019-01521-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Fukatsu K, Nagayoshi H, Maeshima Y, Ueno C, Saitoh D, Mochizuki H. Fish oil infusion reverses 5-fluorouracil-induced impairments in mucosal immunity in mice. Clin Nutr 2008;27:269-75. [PMID: 18249477 DOI: 10.1016/j.clnu.2007.12.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
27 D'Amico L, Ajami NJ, Adachi JA, Gascoyne PR, Petrosino JF. Isolation and concentration of bacteria from blood using microfluidic membraneless dialysis and dielectrophoresis. Lab Chip 2017;17:1340-8. [PMID: 28276545 DOI: 10.1039/c6lc01277a] [Cited by in Crossref: 38] [Cited by in F6Publishing: 10] [Article Influence: 12.7] [Reference Citation Analysis]
28 Takahashi H, Kawaguchi M, Kitamura K, Narumiya S, Kawamura M, Tengan I, Nishimoto S, Hanamure Y, Majima Y, Tsubura S, Teruya K, Shirahata S. An Exploratory Study on the Anti-inflammatory Effects of Fucoidan in Relation to Quality of Life in Advanced Cancer Patients. Integr Cancer Ther 2018;17:282-91. [PMID: 28627320 DOI: 10.1177/1534735417692097] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 9.8] [Reference Citation Analysis]
29 Kucuk C, Ozkan M, Akgun H, Muhtaroglu S, Sozuer E. The Effect of Granulocyte Macrophage-Colony Stimulating Factor on Bacterial Translocation after Administration of 5-Fluorouracil in Rats. Journal of Surgical Research 2005;128:15-20. [DOI: 10.1016/j.jss.2005.04.037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
30 Freitas APF, Bitencourt FS, Brito GAC, de Alencar NMN, Ribeiro RA, Lima-júnior RCP, Ramos MV, Vale ML. Protein fraction of Calotropis procera latex protects against 5-fluorouracil-induced oral mucositis associated with downregulation of pivotal pro-inflammatory mediators. Naunyn-Schmiedeberg's Arch Pharmacol 2012;385:981-90. [DOI: 10.1007/s00210-012-0778-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
31 Donnelly JP, Blijlevens NM, van der Velden WJ. Host impairments in patients with neoplastic diseases. Cancer Treat Res 2014;161:1-41. [PMID: 24706220 DOI: 10.1007/978-3-319-04220-6_1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
32 Nagayoshi H, Fukatsu K, Ueno C, Hara E, Maeshima Y, Omata J, Hiraide H, Mochizuki H. 5-Fluorouracil Infusion Reduces Gut-Associated Lymphoid Tissue Cell Number and Mucosal Immunoglobulin A Levels. JPEN J Parenter Enteral Nutr 2017;29:395-400. [DOI: 10.1177/0148607105029006395] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
33 Halim T, Song K, Barnett M, Forrest D, Hogge D, Nantel S, Nevill T, Shepherd J, Smith C, Sutherland H, Toze C, Lavoie J. Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia. Annals of Oncology 2007;18:1246-52. [DOI: 10.1093/annonc/mdm112] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
34 Herbers AH, Blijlevens NM, Donnelly JP, de Witte TJ. Bacteraemia coincides with low citrulline concentrations after high-dose melphalan in autologous HSCT recipients. Bone Marrow Transplant. 2008;42:345-349. [PMID: 18587437 DOI: 10.1038/bmt.2008.170] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
35 Tetz GV, Ruggles KV, Zhou H, Heguy A, Tsirigos A, Tetz V. Bacteriophages as potential new mammalian pathogens. Sci Rep 2017;7:7043. [PMID: 28765534 DOI: 10.1038/s41598-017-07278-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
36 Wood LJ, Weymann K. Inflammation and neural signaling: etiologic mechanisms of the cancer treatment-related symptom cluster. Curr Opin Support Palliat Care 2013;7:54-9. [PMID: 23314015 DOI: 10.1097/SPC.0b013e32835dabe3] [Cited by in Crossref: 55] [Cited by in F6Publishing: 30] [Article Influence: 6.9] [Reference Citation Analysis]
37 Blijlevens NMA, Donnelly JP, Depauw BE. Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients. Bone Marrow Transplant 2005;36:703-7. [DOI: 10.1038/sj.bmt.1705118] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
38 Konstantinov SR. Diet, microbiome, and colorectal cancer. Best Practice & Research Clinical Gastroenterology 2017;31:675-81. [DOI: 10.1016/j.bpg.2017.09.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]